Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2010
03/10/2010CN101668539A Duck embryonic derived stem cell lines for the production of viral vaccines
03/10/2010CN101665536A Anti-vegf antibodies
03/10/2010CN101664550A Method and medicament for treating or preventing cancers
03/10/2010CN101664549A Process for purifying antigen of foot and mouth disease vaccine
03/10/2010CN101664388A transnasal transport/immunisation with highly adaptable carriers
03/10/2010CN100593544C Mutants of the P4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
03/09/2010US7674892 Hsp70 from Arthrobacter
03/09/2010US7674888 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
03/09/2010US7674887 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
03/09/2010US7674884 Neutralizing antibodies and methods of use thereof
03/09/2010US7674880 Anthrax and small pox replikins and methods of use
03/09/2010US7674777 Immunostimulatory nucleic acid molecules
03/09/2010US7674769 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (TFPI)
03/09/2010US7674606 Protein isolation
03/09/2010US7674604 Using computer modeling to identify positions where cysteinal insertion will lock protein comprising integrin domain sequences into preferential configuration; directed protein evolution
03/09/2010US7674591 Methods of using antibodies to human IL-13bc for inhibiting IL-13 binding
03/09/2010US7674470 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis
03/09/2010US7674469 Feline influenza vaccine and method of use
03/09/2010US7674468 Herpes simplex virus (HSV) comprising deletion, insertion, or substitution in each gamma 34.5 gene; lysis
03/09/2010US7674467 Using pulsed field gel electrophoresis (PFGE) as diagnostic patterning tool for detection of bacterial infection
03/09/2010US7674466 Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells using antibodies that bind to ICAM-1
03/09/2010US7674465 Regulation of gene expression by the Bacillus anthracis ARP
03/09/2010US7674464 Intracellular interleukin-1 receptor antagonists
03/09/2010US7674462 Transforming growth factor receptor specific immunoglobulin for use in diagnosis prvention and treatment of tumor disorders; immunotherapy
03/09/2010US7674461 Monoclonal antibody to interleukins polypeptide for treating and preventing inflammatory bowel, crohn's, arthritis and psoriasis disorders
03/09/2010US7674460 Compositions and methods for restoring sensitivity to treatment with HER2 antagonists
03/09/2010US7674459 treatment of Interleukin13 dependent neoplastic disorders; high affinity to both glycosylated and non-glycosylated human IL13; do not bind mouse IL13, and neutralize human IL13 activity at an approximate molar ratio of 1:2 (MAb:IL13)
03/09/2010US7674456 Breast cancer cell lines and uses thereof
03/09/2010US7674453 Tumor necrosis factor combined with interferon in demyelinating diseases
03/05/2010CA2679676A1 Monoclonal antibodies for neutralizing anthrax toxin
03/05/2010CA2654756A1 Vaccination for lawsonia intracellularis
03/04/2010WO2010025469A1 West nile virus vaccine
03/04/2010WO2010025400A2 Cross-reactive and bispecific anti-el 17a/f antibodies
03/04/2010WO2010025109A1 Vaccine against highly pathogenic porcine reproductive and respiratory syndrome (hp prrs)
03/04/2010WO2010025050A2 Affecting bone related conditions using cd68 blocking agents
03/04/2010WO2010024897A2 Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer
03/04/2010WO2010024719A1 Process for preparing an anti-tumour vaccine
03/04/2010WO2010024676A1 Delivery of a cd40 agonist to a tumor draining lymph node of a subject
03/04/2010WO2010024432A1 Therapeutic agent for central nervous system injury
03/04/2010WO2010024284A1 Anti-viral vaccine for fish, immunostimulating agent for fish, and immunostimulation method for fish
03/04/2010WO2010024118A1 Novel recombinant protein having caspase recruitment domain applied thereto, and use thereof
03/04/2010WO2010024108A1 Prophylactic or therapeutic agent for influenza virus infection
03/04/2010WO2010023498A1 Methods of enhancing adjuvanticity of vaccine compositions
03/04/2010WO2010023452A2 Nematode vaccine
03/04/2010WO2010023382A1 Induction of p53 expression by neutralization of neuropilin-2 for the treatment of cancers
03/04/2010WO2010023366A1 Rough lps as an immunostimulant in aquatic farming
03/04/2010WO2010023260A1 Vaccine compositions
03/04/2010WO2010023247A1 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies.
03/04/2010WO2010023216A1 Vaccine
03/04/2010WO2010022740A2 Hiv-1 envelope polypeptides for hiv vaccine
03/04/2010WO2010022737A1 Anti-cd5 antibodies
03/04/2010WO2010022734A1 Treatment of thrombocytopenia
03/04/2010WO2010022463A1 Prevention, treatment and diagnosis of p.gingivalis infection
03/04/2010WO2010022452A1 Methods and compositions for treating and preventing malaria using an invasion ligand directed to a protease-resistant receptor
03/04/2010WO2010006296A3 New avian bornavirus
03/04/2010WO2010000849A3 Conserved secreted proteins from protozoan parasites
03/04/2010WO2009152986A8 Muc16 fragments with antigenic activity and pharmaceutical compositions thereof
03/04/2010WO2009149306A9 Complement depleting compounds and methods of treating cancer comprising monoclonal antibody therapy and said complement depleting compounds
03/04/2010WO2009140676A3 Compositions and methods for inhibition of retroviruses
03/04/2010WO2009137378A3 Sequential administration of chemotherapeutic agents for treatment of cancer
03/04/2010WO2009135199A3 Vaccine compositions and methods
03/04/2010WO2009120810A3 Neurodegenerative disorders
03/04/2010WO2009117134A3 Aerosolized genetic vaccines and methods of use
03/04/2010WO2009105152A3 Virus-like particles as vaccines for paramyxovirus
03/04/2010WO2009023955A8 Cytotoxicity mediation of cells evidencing surface expression of cd9
03/04/2010US20100057047 Delivery device and method
03/04/2010US20100056447 Immunization against chlamydia pneumoniae
03/04/2010US20100055183 Trimeprazine and ethopropazine derivatives for promoting bone growth
03/04/2010US20100055170 Metal core nanocapsules
03/04/2010US20100055167 Stem cell delivery of anti-neoplastic medicine
03/04/2010US20100055166 Novel method and compositions
03/04/2010US20100055147 Angiotensin (1-7) eluting stent
03/04/2010US20100055138 Methods and topical formulations comprising colloidal metal for treating or preventing skin conditions
03/04/2010US20100055136 Tumour Vaccine Comprising Allogenic or Xenogeneic Tumour Cells
03/04/2010US20100055135 Enhancin of hepatitis b virus vaccine and its gene
03/04/2010US20100055134 Method of separating protective components of bordetella pertussis
03/04/2010US20100055133 Pharmaceutical compositions
03/04/2010US20100055132 Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
03/04/2010US20100055131 Reovirus compositions and methods of use
03/04/2010US20100055130 Staphylococcus aureus proteins and nucleic acids
03/04/2010US20100055129 Modulators of myc, methods of using the same, and methods of indentifiying agents that modulate myc
03/04/2010US20100055128 Method for the purification of alphavirus replicon particles
03/04/2010US20100055127 Procedure For Expressing A Tbpb Protein On The Bacterial Surface Of An Attenuated Oral Live Vaccine As Prototype Of A Meningitis B Vaccine
03/04/2010US20100055126 Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
03/04/2010US20100055125 Peptide Library
03/04/2010US20100055124 BRACHYSPIRA PILOSICOLI 72kDa OUTER-MEMBRANE PROTEIN AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
03/04/2010US20100055123 Vaccine against burkholderia infections
03/04/2010US20100055122 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
03/04/2010US20100055121 Brachyury polypeptides and methods for use
03/04/2010US20100055120 Prostate stem cell antigen (psca) variants and subsequences thereof
03/04/2010US20100055119 Peptides sequences and compositions
03/04/2010US20100055118 Peptidic Growth Hormone Secretagogues Analog Compounds and Preparations Thereof
03/04/2010US20100055117 Allorestricted peptide-specific t cells
03/04/2010US20100055116 Methods and Compositions for Targeting c-Rel
03/04/2010US20100055115 Compositions and methods for stem cell delivery
03/04/2010US20100055114 Use of integrin alpha 10 binding antibody to modulate extracellular matrix (cartilage) turnover
03/04/2010US20100055113 Cellular receptor for antiproliferative factor
03/04/2010US20100055112 Enterococcus faecalis and/or Enterococcus faecium antigen
03/04/2010US20100055111 Indoleamine 2,3-dioxygenase, pd-1/pd-l pathways, and ctla4 pathways in the activation of regulatory t cells
03/04/2010US20100055110 congestive heart failure, coronary restenosis, myocardial infarction, myocardial dysfunction, stroke and atherosclerosis; time-release and sustained-release drugs
1 ... 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 ... 1823